Larisa V Debelenko

Summary

Affiliation: St. Jude Children's Research Hospital
Country: USA

Publications

  1. ncbi p53+/mdm2- atypical lipomatous tumor/well-differentiated liposarcoma in young children: an early expression of Li-Fraumeni syndrome
    Larisa V Debelenko
    Department of Pathology, Children s Hospital Boston, 300 Longwood Avenue, Boston, MA 02115, USA
    Pediatr Dev Pathol 13:218-24. 2010
  2. ncbi D2-40 immunohistochemical analysis of pediatric vascular tumors reveals positivity in kaposiform hemangioendothelioma
    Larisa V Debelenko
    Department of Pathology, Children s Hospital, Harvard Medical School, Boston, MA, USA
    Mod Pathol 18:1454-60. 2005
  3. ncbi A novel EWSR1-CREB3L1 fusion transcript in a case of small cell osteosarcoma
    Larisa V Debelenko
    Department of Pathology, Wayne State University, Detroit, MI, USA
    Genes Chromosomes Cancer 50:1054-62. 2011
  4. ncbi Novel karyotypes in giant cell-rich lesions of bone
    Briana C Gleason
    Department of Pathology, Children s Hospital, Boston, MA 02115, USA
    Am J Surg Pathol 31:926-32. 2007
  5. ncbi Renal cell carcinoma with novel VCL-ALK fusion: new representative of ALK-associated tumor spectrum
    Larisa V Debelenko
    Department of Pathology, St Jude Children s Research Hospital, Memphis, TN, USA
    Mod Pathol 24:430-42. 2011

Collaborators

Detail Information

Publications5

  1. ncbi p53+/mdm2- atypical lipomatous tumor/well-differentiated liposarcoma in young children: an early expression of Li-Fraumeni syndrome
    Larisa V Debelenko
    Department of Pathology, Children s Hospital Boston, 300 Longwood Avenue, Boston, MA 02115, USA
    Pediatr Dev Pathol 13:218-24. 2010
    ..Recognition of this lesion and its association is important for early diagnosis and subsequent tumor surveillance in the proband and affected family members...
  2. ncbi D2-40 immunohistochemical analysis of pediatric vascular tumors reveals positivity in kaposiform hemangioendothelioma
    Larisa V Debelenko
    Department of Pathology, Children s Hospital, Harvard Medical School, Boston, MA, USA
    Mod Pathol 18:1454-60. 2005
    ..Further studies are necessary to define the identity of the D2-40 antigen and to elucidate the biologic significance of its selective lymphothelial reactivity....
  3. ncbi A novel EWSR1-CREB3L1 fusion transcript in a case of small cell osteosarcoma
    Larisa V Debelenko
    Department of Pathology, Wayne State University, Detroit, MI, USA
    Genes Chromosomes Cancer 50:1054-62. 2011
    ..The 3'-end partner and the inferred structure of EWSR1-CREB3L1, however, are different from those of Ewing sarcoma, suggesting different targets of the new oncogene...
  4. ncbi Novel karyotypes in giant cell-rich lesions of bone
    Briana C Gleason
    Department of Pathology, Children s Hospital, Boston, MA 02115, USA
    Am J Surg Pathol 31:926-32. 2007
    ..Further cytogenetic characterization of giant cell-rich bone lesions may improve the utility of karyotyping as a tool in their differential diagnosis and may shed light on the pathogenetic relationship between these lesions...
  5. ncbi Renal cell carcinoma with novel VCL-ALK fusion: new representative of ALK-associated tumor spectrum
    Larisa V Debelenko
    Department of Pathology, St Jude Children s Research Hospital, Memphis, TN, USA
    Mod Pathol 24:430-42. 2011
    ..The results should prompt further studies to advance the molecular classification of renal cell carcinoma and help to select patients who would benefit from appropriate targeted therapies...